ORAI2 and inflammatory bowel disease: Only combined, but not individual, deletion of Orai1 and Orai2 abolishes SOCE completely and interferes with protective antibody responses against viral infection, and prevents autoimmune and alloimmune inflammation in models of inflammatory bowel disease (IBD) and graft-versus-host disease (GvHD), respectively.